instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: Rather than outline specific recommendations, the 300-page document is meant to be a resource for state regulators as they begin the process in 2020 of drafting formal rules aimed at reducing methane emissions. Despite industry claims that companies have been able to reduce emissions while still setting production records, environmentalists have been pushing hard for more regulations at the state level to target methane leaks and the practice of venting and flaring. The report is the result of numerous meetings over the last four months by the Methane Advisory Panel, a group of more than two dozen experts knowledgeable about various parts of the oil and gas business. The panel included industry representatives, environmental lawyers and experts from Los Alamos National Laboratory, Colorado State University and the New Mexico Institute of Mining and Technology. The discussions centered on topics like compressor engines, storage tanks and pneumatic valves. New Mexico Environment Secretary James Kenney said the effort put into the report is unparalleled in its thoroughness. “This is exactly the baseline information we need to effectively tackle methane emissions in our state,” he said. The state will be accepting public comment on the report through Feb. 20. XTO Energy President Staale Gjervik said the company’s experience shows methane emissions can be mitigated in a cost-effective way but that full industry participation is important. XTO was among those represented on the panel. The report highlights various strategies to reduce emissions, such as switching to low- or no-bleed pneumatic controllers and increasing leak detection and monitoring equipment. The need for more infrastructure also was identified as a possible way to reduce venting and flaring — although the report stated flaring, or the burning off of excess natural gas during extraction, was a necessary part of the process. The state will host public meetings in the coming months to discuss the findings with community members across the state. Stronger regulations for methane emissions will be critical as the oil boom in New Mexico continues, said Hillary Hull of the Environmental Defense Fund, another member of the advisory panel. She said the state’s process in developing the analysis was been inclusive, representing countless hours of research and input from a diverse cross-section of stakeholders. “Next year will be the critical time for moving forward on enforceable, nationally-leading methane rules that protect our air, address the climate crisis and improve education funding for New Mexico families and future generations,” she said. Earlier this month, trade groups representing the oil and gas industries in New Mexico and Texas release an analysis that showed a decline in methane emissions in both states as production tripled. The research also showed that the amount of methane burned off or emitted per barrel of oil equivalent was reduced by 64 percent in the Permian Basin during the past seven years. Meanwhile, the report cited a 210% increase in oil production in the Permian since 2011. Ryan Flynn, executive director at the New Mexico Oil and Gas Association said Permian producers are leading the industry when it comes to environmental practices and emissions reductions. “As energy markets across the globe look to America for their energy needs, we are creating the solutions of the future to deliver cleaner, more reliable energy to people and communities in every corner of the planet,” he said in a statement. Claim: New Mexico releases methane emissions report.
answer:
An advisory panel has released a technical report that covers how emissions are produced by oil and natural gas development and how New Mexico might be able to curb pollution from the industry.


question:
Paragraph: Attorney and Democratic state Sen. Jacob Candelaria recently filed a lawsuit in state district court on behalf of Joe Montano, who said authorities recently seized his medical cannabis, KOAT-TV reports. According to court documents, correctional officers searched Montano’s home while he was on house arrest, found the marijuana, and put him in jail for a month as punishment. The petition is seeking a judge to order the jail to allow him to possess and use his medical marijuana. State lawmakers passed a measure last year to allow people on house arrest to use medical marijuana. In a statement, Metropolitan Detention Center Chief of Corrections Ralph Fernadez said Community Custody Program inmates are considered in jail custody, and medical marijuana use is prohibited in the detention center. Claim: New Mexico man in house arrest sues to use medical marijuana.
answer:
A New Mexico man serving a house arrest sentence for drunken driving is suing to be allowed to use medical marijuana.


question:
Paragraph: "Accusations about the responsible party behind the United States’ struggle to accelerate coronavirus testing have come from every which way and the blame has fallen, often inaccurately, on the shoulders of different public officials. In a March 13 tweet, President Donald Trump said the Centers for Disease Control and Prevention studied its testing system for decades but wasn’t prepared for a large scale pandemic, an issue that was complicated by policy changes made by former President Barack Obama. U.S. Sen. Chuck Schumer, D-N.Y., retweeted Trump’s remark and added his own comment: ""Trump is once again trying to blame the previous administration for the number of tests available. This is his #DailyLie."" U.S. Rep. Dan Crenshaw, R-Houston, retweeted Schumer’s remark and said: ""It’s not Obama’s fault and it’s not Trump’s fault. We have stringent FDA regulations, long in place, that created barriers to the private industry creating a test quickly."" PolitiFact looked at a different Trump claim blaming Obama for a lack of testing. We also looked at a claim from Democrat Joe Biden about the Trump administration rejecting tests from the World Health Organization (they were never offered). Trump also inaccurately stated that any individual who wants to be tested for the coronavirus can get a test. We wanted to dig deeper into Crenshaw’s claim, which attributes the delays in the availability of widespread testing to Food and Drug Administration regulations. Justin Discigil, spokesman for Crenshaw, pointed to articles from ProPublica, the New Yorker, The Atlantic and the Washington Post, all of which highlighted the role FDA regulations played here. He added: ""Just to be clear – nowhere did we say that these regulations were the sole/only reason for the testing issue, we said that they created barriers."" A timeline of events The first confirmed case of COVID-19 in the United States came at the end of January, when a man in Washington state developed symptoms after returning from a trip to Wuhan. One month later, federal health officials at the Centers for Disease Control and Prevention said it was inevitable that the U.S. would experience a spread of the virus and urged people to take precautions. In these early days of the virus, tests were not widely distributed to local and state laboratories. Instead, testing for the new coronavirus was conducted almost entirely by the CDC — samples collected at the local level were sent to the agency. Initial test kits developed by the CDC for use in local and state labs were flawed and produced inaccurate results in some labs, meaning they couldn’t be distributed. As the agency worked to correct the tests, health officials turned to the FDA. The U.S. Association of Public Health Laboratories submitted a letter asking the agency to use ""enforcement discretion"" and authorize local and state labs to develop and use their own tests. During a public health emergency, labs and drug manufacturers must seek an Emergency Use Authorization from the FDA to use diagnostic tests and medical treatments that have not gone through the typical clearance process — to share them faster in the emergency. (These authorizations were begun in 2004 under President George W. Bush.) For laboratory-developed tests, like the ones in question, FDA policy has stated that they cannot be used in clinical diagnoses without the FDA’s approval during an emergency. Although the goal of these regulations is to ensure only accurate lab tests are conducted, health officials have said they prevented them from quickly responding to the virus. One doctor in a Seattle lab described the process for getting an Emergency Use Authorization from the FDA and said the agency asked for a level of testing that didn’t make sense in the context of an emergency, according to a GQ profile. A doctor in North Carolina told NBC News that she had developed a test using the World Health Organization’s protocol but had yet to receive the use authorization from the FDA, putting the state ""way behind"" in its ability to test patients. On Feb. 29, the FDA announced a change in the process: Labs would still need to seek the agency’s approval for their tests, but the labs could begin testing while waiting for the official green light. On March 16, (three days after Crenshaw made his claim) the FDA announced another change to its policies and put state officials in charge of coronavirus tests developed by laboratories in their states, meaning labs would engage with state officials and not the FDA. It also removes the requirement for these labs to apply for an Emergency Use Authorization for their tests. The changes also expand which labs and manufacturers are included in FDA guidelines and which kinds of tests can be developed. ""We believe the unprecedented policy set forth in today’s updated guidance, which addresses laboratories and commercial manufacturers, will help address these urgent public health concerns by helping to expand the number and variety of diagnostic tests, as well as available testing capabilities in health care settings, and reference and commercial laboratories,"" reads a release from the agency. After the changes After the FDA announced changes to its policies, Labcorps and Quest Diagnostics both announced plans to start testing for the new coronavirus, crediting changes in federal policy with their ability to do so. ""We applaud the FDA for providing the flexibility for innovative, quality lab developed tests to be brought to patients and providers quickly to advance effective response to the coronavirus outbreak,"" said Steve Rusckowski, chairman and chief executive officer of Quest Diagnostics, in a statement. But even as state and local authorities move to ramp up testing, the number of available tests is still lacking. In Austin, for example, there is still a gap between available test kids and demand for testing, as officials prioritize testing for health care workers, people living in nursing homes and people at high risk for complications from the virus. Our Ruling Crenshaw said in a tweet that longstanding FDA regulations ""created barriers to the private industry creating a test quickly"" for the coronavirus. Crenshaw’s statement is accurate. FDA procedures adopted in 2004 meant laboratories had to seek the agency’s approval before developing and using tests in communities, a policy many health care officials have said prevented the country from taking early action in response to the novel coronavirus. It is important to keep in mind that other factors have contributed to the low levels of testing for the virus, beyond the FDA regulations. But Crenshaw’s statement is accurate." Claim: Dan Crenshaw Says longstanding Food and Drug Administration regulations “created barriers to the private industry creating a test quickly” for the coronavirus.
answer:

Food and Drug Administration regulations in place since 2004 require labaratories to get an Emergency Use Authorization from the agency to use diagnostic tests and medical treatments that haven't gone through the typical clearance process. The policy was intended to speed up the process, but researchers reported significant delays between seeking an application and getting approval and these regulations played a role in that. The FDA has since changed the regulations to allow labs to start utilizing tests before receiving clearance.